Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Jul;50(7):i-vi.
doi: 10.18502/ijph.v50i7.6656.

A Brief Overview of COVID-19 Vaccines

Dariush D Farhud  1   2   3 , Shaghayegh Zokaei  3   4
Affiliations
Editorial

A Brief Overview of COVID-19 Vaccines

Dariush D Farhud et al. Iran J Public Health. 2021 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest The authors declare that there is no conflict of interests.

Figures

Fig. 1:
Fig. 1:
Total number of single dose vaccine administered in the countries with the highest injection rates until June19, 2021. Due to the specific dose regime, it does not represent the total number of people vaccinated (e.g. people receive multiple doses). Iran is included in the chart just for comparison (18)
Fig. 2:
Fig. 2:
Share of people vaccinated against COVID-19, which is only available for countries that administered both first and second doses until June19, 2021. The countries with the highest injection rates are listed, and Iran is included in the chart just for comparison (19)
Fig. 3:
Fig. 3:
The total number of administered COVID-19 vaccine per 100 people in the general population until June19, 2021, which is counted as a single dose and does not represent the total number of people vaccinated (e.g. people receive multiple doses). The countries with the highest injection rates are listed, and Iran is included in the chart just for comparison (20)
Fig. 4:
Fig. 4:
Share of the population that is fully vaccinated prescribed by the vaccination protocol until June19, 2021. This data is only available for countries that administered both first and second doses. The countries with the highest injection rates are listed, and Iran is included in the chart just for comparison (21)
See this image and copyright information in PMC

References

    1. Cui J, Li F, Shi ZL. (2019). Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol, 17:181–192. - PMC - PubMed
    1. Alturki SO, Alturki SO, Connors J, Cusimano G, Kutzler MA, Izmirly AM, Haddad EK. (2020). The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development. Front Immunol, 11:1880. - PMC - PubMed
    1. Krammer F. (2020). SARS-CoV-2 vaccines in development. Nature, 586:516–527. - PubMed
    1. Martin JE, Louder MK, Holman LA, et al. (2008). A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial. Vaccine, 26:6338–43. - PMC - PubMed
    1. Wang H, Yang P, Liu K, Guo F, Zhang Y, Zhang G, Jiang C. (2008). SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway. Cell Res, 18:290–301. - PMC - PubMed

Publication types

LinkOut - more resources